TAK Stock Price, Chart, Stats & News
Takeda Pharmaceutical Company Limited (TAK) is a dividend-paying stock with a current dividend yield of 3.81% as of Jul 10, 2026. It pays $0.6304 per share over the trailing twelve months and distributes bi-annually. Its dividend has grown at a -5.51% 5-year compound annual rate.
Dividend safety
Dividend coverage looks healthy — TAK pays out about 37% of earnings.
TAK chart
Fundamentals
Gross margin | 62.11% |
Operating margin | 8.31% |
Pretax margin | 4.63% |
Net margin | 2.56% |
Effective tax rate | 44.63% |
ROA | 0.74% |
ROE | 1.61% |
D/E | 0.64x |
Interest coverage ratio | 1.18x |
TAK valuation
P/E | 9.63x |
P/S | 2.02x |
P/B | 1.19x |
P/CF | 7.71x |
P/FCF | 9.48x |
P/OCF | 7.71x |
PEG | 0.00x |
EV multiple | 3.49x |
About
Takeda Pharmaceutical Company Limited is a prominent global biopharmaceutical entity dedicated to the discovery, development, manufacturing, commercialization, and out-licensing of pharmaceutical products. The company's operations extend across a vast international footprint, encompassing Japan, the United States, Europe, Canada, Latin America, Russia, and numerous other Asian and worldwide markets. Its extensive portfolio of medicines targets critical therapeutic areas, including digestive disorders (gastroenterology), rare diseases, plasma-derived treatments, cancer care (oncology), and neurological conditions.
Related lists
Similar securities
Based on sector and market capitalization
